Fortress Biotech, Inc. (FBIO) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Fortress Biotech, Inc. (FBIO) Bundle
Designed for accuracy, our (FBIO) DCF Calculator enables you to evaluate the valuation of Fortress Biotech, Inc. using real-world financial data while offering complete flexibility to modify all essential parameters for improved projections.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36.6 | 45.6 | 68.8 | 75.7 | 84.5 | 105.0 | 130.5 | 162.1 | 201.5 | 250.4 |
| Revenue Growth, % | 0 | 24.49 | 50.86 | 10.11 | 11.58 | 24.26 | 24.26 | 24.26 | 24.26 | 24.26 |
| EBITDA | -85.2 | -87.8 | -142.3 | -190.5 | -133.6 | -105.0 | -130.5 | -162.1 | -201.5 | -250.4 |
| EBITDA, % | -232.49 | -192.59 | -206.79 | -251.47 | -158.13 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 4.7 | 5.3 | 6.8 | 9.4 | 8.1 | 11.8 | 14.7 | 18.2 | 22.6 | 28.1 |
| Depreciation, % | 12.71 | 11.68 | 9.87 | 12.35 | 9.55 | 11.23 | 11.23 | 11.23 | 11.23 | 11.23 |
| EBIT | -89.8 | -93.1 | -149.0 | -199.8 | -141.7 | -105.0 | -130.5 | -162.1 | -201.5 | -250.4 |
| EBIT, % | -245.19 | -204.27 | -216.66 | -263.82 | -167.69 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 136.9 | 233.4 | 305.7 | 178.3 | 80.9 | 104.1 | 129.4 | 160.8 | 199.8 | 248.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 14.4 | 19.3 | 23.8 | 28.3 | 15.4 | 36.1 | 44.9 | 55.8 | 69.3 | 86.1 |
| Account Receivables, % | 39.32 | 42.43 | 34.58 | 37.42 | 18.21 | 34.39 | 34.39 | 34.39 | 34.39 | 34.39 |
| Inventories | .9 | 1.4 | 9.9 | 14.2 | 10.2 | 10.6 | 13.2 | 16.4 | 20.4 | 25.3 |
| Inventories, % | 2.34 | 3.08 | 14.34 | 18.69 | 12.08 | 10.1 | 10.1 | 10.1 | 10.1 | 10.1 |
| Accounts Payable | 35.5 | 11.4 | 47.4 | 57.2 | 34.8 | 64.6 | 80.3 | 99.7 | 123.9 | 154.0 |
| Accounts Payable, % | 96.78 | 25.03 | 68.95 | 75.58 | 41.19 | 61.5 | 61.5 | 61.5 | 61.5 | 61.5 |
| Capital Expenditure | -9.4 | -7.2 | -16.3 | -3.1 | -.1 | -14.5 | -18.1 | -22.5 | -27.9 | -34.7 |
| Capital Expenditure, % | -25.65 | -15.71 | -23.76 | -4.03 | -0.07454474 | -13.85 | -13.85 | -13.85 | -13.85 | -13.85 |
| Tax Rate, % | 60.53 | 60.53 | 60.53 | 60.53 | 60.53 | 60.53 | 60.53 | 60.53 | 60.53 | 60.53 |
| EBITAT | -45.8 | -93.3 | -149.5 | -200.2 | -55.9 | -82.0 | -101.9 | -126.6 | -157.3 | -195.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -30.3 | -124.6 | -135.9 | -193.0 | -53.4 | -76.1 | -101.0 | -125.5 | -155.9 | -193.7 |
| WACC, % | 7.89 | 13.31 | 13.31 | 13.31 | 6.62 | 10.89 | 10.89 | 10.89 | 10.89 | 10.89 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -461.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -198 | |||||||||
| Terminal Value | -2,222 | |||||||||
| Present Terminal Value | -1,325 | |||||||||
| Enterprise Value | -1,787 | |||||||||
| Net Debt | 8 | |||||||||
| Equity Value | -1,794 | |||||||||
| Diluted Shares Outstanding, MM | 8 | |||||||||
| Equity Value Per Share | -221.24 |
What You Will Get
- Pre-Filled Financial Model: Fortress Biotech’s actual data enables precise DCF valuation.
- Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
- Instant Calculations: Automatic updates ensure you see results as you make changes.
- Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
- Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as research and development costs, market penetration rates, and projected revenue growth.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
- High-Precision Results: Leverages Fortress Biotech’s actual financial data for accurate valuation insights.
- Effortless Scenario Analysis: Easily evaluate various assumptions and analyze different potential outcomes.
- Efficiency Booster: Streamline the valuation process without the need to create intricate models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based FBIO DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
- Instant Calculations: The model automatically recalculates Fortress Biotech’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial analysis.
Why Choose This Calculator for Fortress Biotech, Inc. (FBIO)?
- Designed for Experts: A sophisticated tool utilized by analysts, CFOs, and industry consultants.
- Accurate Data: Fortress Biotech's historical and projected financials preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly: Step-by-step guidance to navigate through the calculations seamlessly.
Who Should Use Fortress Biotech, Inc. (FBIO)?
- Investors: Gain insights into the biotech sector with a robust analysis tool tailored for informed decision-making.
- Financial Analysts: Streamline your workflow with a pre-designed financial model that can be easily customized.
- Consultants: Effortlessly modify the template for impactful client presentations or detailed reports.
- Biotech Enthusiasts: Enhance your knowledge of the industry with practical examples and case studies.
- Educators and Students: Utilize it as an effective resource for teaching and learning in biotechnology and finance courses.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Fortress Biotech, Inc. (FBIO).
- Real-World Data: Fortress Biotech’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to Fortress Biotech, Inc. (FBIO).
- Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for informed decision-making.